Biocompatibility devices

The high-molecular-weight of HA together with its special viscoelastic features and biological functions has made HA as an attractive material to prepare biocompatible devices with applications in drug delivery and tissue engineering [108-111],... 

The applications of monolayers range from the development of electronic components and biocompatible devices to lubricating thin layers, corrosion prevention, and so on. The aim of this chapter is to sketch the structure, properties, and preparation methods of monolayers and to discuss the relevant most important electroanalytical applications it is focused oti the most commOTi monolayers used in the frame of amperometric sensors. 

Altogether, the mechanical environment in which the device will act is extremely important in the design phase in particular, the correct estimation of how the device will be loaded is necessary to successfully design a biocompatible device that is able to produce, in its whole lifetime, a quantity and typology of degradation products that can be tolerated by the host tissues. 

To this day, we still hear people claim that in vitro testing of materials alone shows that they are suitable for use in chronically implanted devices. Others continue to say that I proved the materials are biocompatible and biostable, so I don t have to do any device testing. This statement can be very far from the truth. In vitro testing has its place, primarily to screen materials and processes for further testing. In some cases where no suitable in vitro test exists, one may be forced to develop accelerated in vivo materials tests. Once the preliminary testing is accomplished, however, one must test the device per se in animals. A biocompatible material does not necessarily make a biocompatible device. The same may be said about biostability. These statements are true because shape, size, surface finish, interactions between the materials in the device, etc., all can affect its biocompatibility and biostability. But even well-performed animal studies may not unveil previously unknown mechanisms, because animals do not perfectly mimic the human in vivo environment. An excellent example of this is the subclavian crush in humans (clamping a lead between the clavicle and first rib), which is impossible to discover in animals with no clavicles. With the right protocol for the device in question, only postmarket surveillance appropriate for the device in question can determine for certain that the device does or does not meet expectations. 

The hydrophobic nature of polysiloxanes has limited their uses in biomedical appHcations, especially in those involving biocompatible devices. Obviously, increasing the hydrophilicity of any polymer surface improves its wettability and this, in turn, improves biocompatibihty. 

The realization of sensitive bioanalytical methods for measuring dmg and metaboUte concentrations in plasma and other biological fluids (see Automatic INSTRUMENTATION BlosENSORs) and the development of biocompatible polymers that can be tailor made with a wide range of predictable physical properties (see Prosthetic and biomedical devices) have revolutionized the development of pharmaceuticals (qv). Such bioanalytical techniques permit the characterization of pharmacokinetics, ie, the fate of a dmg in the plasma and body as a function of time. The pharmacokinetics of a dmg encompass absorption from the physiological site, distribution to the various compartments of the body, metaboHsm (if any), and excretion from the body (ADME). Clearance is the rate of removal of a dmg from the body and is the sum of all rates of clearance including metaboHsm, elimination, and excretion. 

The presence of polymer, solvent, and ionic components in conducting polymers reminds one of the composition of the materials chosen by nature to produce muscles, neurons, and skin in living creatures. We will describe here some devices ready for commercial applications, such as artificial muscles, smart windows, or smart membranes other industrial products such as polymeric batteries or smart mirrors and processes and devices under development, such as biocompatible nervous system interfaces, smart membranes, and electron-ion transducers, all of them based on the electrochemical behavior of electrodes that are three dimensional at the molecular level. During the discussion we will emphasize the analogies between these electrochemical systems and analogous biological systems. Our aim is to introduce an electrochemistry for conducting polymers, and by extension, for any electrodic process where the structure of the electrode is taken into account. 

Non-clinical laboratory studies used to investigate microbiological, toxicological, immunological, biocompatibility, stress, wear, shelf life, and other characteristics of the device. 

The ability of these peptidomimetic collagen-structures to adopt triple helices portends the development of highly stable biocompatible materials with collagenlike properties. For instance, it has been found that surface-immobilized (Gly-Pro-Meu)io-Gly-Pro-NH2 in its triple-helix conformation stimulated attachment and growth of epithelial cells and fibroblasts in vitro [77]. As a result, one can easily foresee future implementations of biostable collagen mimics such as these, in tissue engineering and for the fabrication of biomedical devices. 

New natural polymers based on synthesis from renewable resources, improved recyclability based on retrosynthesis to reusable precursors, and molecular suicide switches to initiate biodegradation on demand are the exciting areas in polymer science. In the area of biomolecular materials, new materials for implants with improved durability and biocompatibility, light-harvesting materials based on biomimicry of photosynthetic systems, and biosensors for analysis and artificial enzymes for bioremediation will present the breakthrough opportunities. Finally, in the field of electronics and photonics, the new challenges are molecular switches, transistors, and other electronic components molecular photoad-dressable memory devices and ferroelectrics and ferromagnets based on nonmetals. 

Initial tests in the rat revealed a high degree of tissue compatibility of Dat-Tyr-Hex derived polymers. More detailed tests are now in progress. In addition, tyrosine derived polymers are currently being evaluated in the formulation of an intracranial controlled release device for the release of dopamine, in the design of an intraarterial stent (to prevent the restenosis of coronary arteries after balloon angioplasty), and in the development of orthopedic implants. The use of tyrosine derived polymers in these applications will provide additional data on the biocompatibility of these polymers. 

As mentioned previously (and discussed in detail in Sec. IX), contact lens products have specific guidelines that focus on compatibility with the contact lens and biocompatibility with the cornea and conjunctiva [75], These solutions are viewed as new medical devices and require testing with the contact lenses with which they are to be used. Tests include a 21-day ocular study in rabbits and employ the appropriate types of contact lenses with which they are to be used and may include the other solutions that might be used with the lens. Additional tests to evaluate cytotoxicity potential, acute toxicity, sensitization potential (allergenicity), and risks specific to the preparation are also required [75-77], These tests are sufficient to meet requirements in the majority of countries, though testing requirements for Japan are currently much more extensive. 

The use of plastics for containers, closures, and medical devices evolved steadily in the second half of the twentieth century. Plastics are durable, easily molded into a variety of shapes, flexible, often unbreakable, and biocompatable in many applications. 

A device that is to be placed in contact with living tissue or biological fluids must be made of material that is biocompatible. However, biocompatible is not a precisely defined term or a measurable property. In general, biocompatibil-... 

Another important property which affects biocompatibility is permeability to low molecular weight solutes, since it is usually required that all extractable materials be leached from the device prior to use. These extractables include lower molecular weight species such as unreacted monomer, residual initiators,... 

Successful applications of materials in medicine have been experienced in the area of joint replacements, particularly artificial hips. As a joint replacement, an artificial hip must provide structural support as well as smooth functioning. Furthermore, the biomaterial used for such an orthopedic application must be inert, have long-term mechanical and biostability, exhibit biocompatibility with nearby tissue, and have comparable mechanical strength to the attached bone to minimize stress. Modem artificial hips are complex devices to ensure these features. 

Apart from modifications in the bulk, also surface modification of PHAs has been reported. Poly(3HB-co-3HV) film surfaces have been subjected to plasma treatments, using various (mixtures of) gases, water or allyl alcohol [112-114]. Compared to the non-treated polymer samples, the wettability of the surface modified poly(3HB-co-3HV) was increased significantly [112-114]. This yielded a material with improved biocompatibility, which is imperative in the development of biomedical devices. 

---